Literature DB >> 4018874

Characterization of the metabolism inhibition antigen of Mycoplasma arthritidis.

L R Washburn, J R Ramsay, L K Roberts.   

Abstract

The Mycoplasma arthritidis antigen(s) responsible for eliciting metabolism-inhibiting antibodies in rabbits has been partially characterized. Metabolism-inhibiting activity was absorbed from rabbit antisera by intact M. arthritidis cells and membranes but much less so by the soluble cytoplasmic fraction, indicating that the antigen is located on the outer membrane surface. It was stable to periodate and lipid extraction but labile to heat and proteolytic enzymes, indicating that it is protein in nature. Finally, it is most likely a tightly bound integral rather than a peripheral membrane protein, since it was not extracted by low-ionic-strength solutions or by the nonionic detergents Triton X-100, Nonidet P-40, and Tween 20. It was solubilized by both the anionic agent sodium deoxycholate and the zwitterionic detergent Zwittergent. Two two monoclonal antibodies with metabolism-inhibiting activity were produced. One recognized a 45,000-dalton surface protein; however, the other recognized an antigen which is probably of cytoplasmic origin, indicating that more than one cell component may be involved in the metabolism-inhibiting antibody response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018874      PMCID: PMC262023          DOI: 10.1128/iai.49.2.357-364.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  THE SEROLOGICAL DIFFERENTIATION OF MYCOPLASMA STRAINS (PLEURO-PNEUMONIA-LIKE ORGANISMS) FROM VARIOUS SOURCES.

Authors:  R M LEMCKE
Journal:  J Hyg (Lond)       Date:  1964-06

2.  A simple procedure for removal of Triton X-100 from protein samples.

Authors:  P W Holloway
Journal:  Anal Biochem       Date:  1973-05       Impact factor: 3.365

3.  Heat-lability and organic solvent-solubility of mycoplasma antigens.

Authors:  G E Kenny
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

4.  Antigenic properties of mycoplasma organisms and membranes.

Authors:  M Argaman; S Razin
Journal:  J Gen Microbiol       Date:  1969-01

5.  Hapten inhibition of the reaction between Mycoplasma mycoides polysaccharide and bovine antisera.

Authors:  S H Buttery
Journal:  Immunochemistry       Date:  1970-03

6.  The evaluation of the metabolic-inhibition technique for the study of Mycoplasma gallisepticum.

Authors:  D Taylor-Robinson; D M Berry
Journal:  J Gen Microbiol       Date:  1969-01

7.  Studies on the effect of growth medium composition on the antigenicity of Mycoplasma bovis.

Authors:  C J Thorns; E Boughton
Journal:  J Hyg (Lond)       Date:  1980-02

8.  An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci.

Authors:  S E Cullen; B D Schwartz
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

9.  Chronic proliferative arthritis of mice induced by Mycoplasma arthritidis. I. Induction of disease and histopathological characteristics.

Authors:  B C Cole; J R Ward; R S Jones; J F Cahill
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

10.  Immunological responses of the rat to Mycoplasma arthritidis.

Authors:  B C Cole; J F Cahill; B B Wiley; J R Ward
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

View more
  10 in total

1.  Comparison of four Mycoplasma arthritidis strains by enzyme immunoassay, metabolism inhibition, one- and two-dimensional electrophoresis, and immunoblotting.

Authors:  L R Washburn; S Hirsch
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Monoclonal antibody E8-18 identifies an integral membrane surface protein unique to Mycoplasma capricolum subsp. capripneumoniae.

Authors:  F R Rurangirwa; P S Shompole; A N Wambugu; S M Kihara; T C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis.

Authors:  T M Bricker; M J Boyer; J Keith; R Watson-McKown; K S Wise
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

4.  Protection of rats against Mycoplasma arthritidis-induced arthritis by active and passive immunizations with two surface antigens.

Authors:  L R Washburn; E J Weaver
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain.

Authors:  L D Olson; S W Shane; A A Karpas; T M Cunningham; P S Probst; M F Barile
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  A 135-kilodalton surface antigen of Mycoplasma hominis PG21 contains multiple directly repeated sequences.

Authors:  S A Ladefoged; S Birkelund; S Hauge; B Brock; L T Jensen; G Christiansen
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.

Authors:  R C Feldmann; B Henrich; V Kolb-Bachofen; U Hadding
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

8.  Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis.

Authors:  H C Riethman; M J Boyer; K S Wise
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Mechanisms of attachment of Mycoplasma arthritidis to host cells in vitro.

Authors:  L R Washburn; S Hirsch; L L Voelker
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Epidemiological investigation of Mycoplasma Synoviae in native chicken breeds in China.

Authors:  Shi-Kai Sun; Xin Lin; Feng Chen; Ding-Ai Wang; Jun-Peng Lu; Jian-Ping Qin; Ting-Rong Luo
Journal:  BMC Vet Res       Date:  2017-04-26       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.